{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:19:02Z","timestamp":1790741942587,"version":"4.1.0"},"reference-count":168,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.jaad.2008.02.043","type":"journal-article","created":{"date-parts":[[2008,4,19]],"date-time":"2008-04-19T09:19:07Z","timestamp":1208596747000},"page":"99-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["The treatment and prognosis of dermatomyositis: An updated review"],"prefix":"10.1016","volume":"59","author":[{"suffix":"III","given":"Luciano J.","family":"Iorizzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Jorizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2008.02.043_bib1","series-title":"Dermatology","first-page":"575","article-title":"Dermatomyositis","author":"Jorizzo","year":"2008"},{"key":"10.1016\/j.jaad.2008.02.043_bib2","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis and inclusion-body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2008.02.043_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mus.10313","article-title":"Inflammatory myopathies: Clinical, diagnostic and therapeutic aspects","volume":"27","author":"Mastaglia","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaad.2008.02.043_bib4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (two-part article)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2008.02.043_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003643.pub2","article-title":"Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis","volume":"3","author":"Choy","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2008.02.043_bib6","doi-asserted-by":"crossref","unstructured":"O'Leary PA, Waisman M. Dermatomyositis: A study of 40 cases. Arch Dermatol Syphilol 1940;41:1001-19.","DOI":"10.1001\/archderm.1940.01490120003001"},{"key":"10.1016\/j.jaad.2008.02.043_bib7","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0190-9622(96)90037-7","article-title":"Guidelines of care for dermatomyositis: American Academy of Dermatology","volume":"34","author":"Drake","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-4362.2000.00851.x","article-title":"Review article: a therapeutic update on dermatomyositis\/polymyositis","volume":"39","author":"Ghate","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nmd.2005.12.008","article-title":"Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future","volume":"16","author":"Dalakas","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jaad.2008.02.043_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00002281-198901040-00005","article-title":"Treatment of polymyositis and dermatomyositis","volume":"1","author":"Dalakas","year":"1989","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2230.1982.tb02449.x","article-title":"The management of lupus erythematosus, scleroderma, lichen sclerosus and dermatomyositis","volume":"7","author":"Rowell","year":"1982","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib12","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2008.02.043_bib13","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0889-857X(02)00028-5","article-title":"Idiopathic inflammatory myopathy: management and prognosis","volume":"28","author":"Oddis","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jaad.2008.02.043_bib14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00019052-200310000-00002","article-title":"Treatment of idiopathic inflammatory myopathies","volume":"16","author":"Amato","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jaad.2008.02.043_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","article-title":"Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis","volume":"56","author":"Bohan","year":"1977","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2008.02.043_bib16","first-page":"207","article-title":"Survival in polymyositis: corticosteroids and risk factors","volume":"4","author":"Carpenter","year":"1977","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0022-510X(75)90115-X","article-title":"Prognosis in adult polymyositis","volume":"26","author":"Riddoch","year":"1975","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jaad.2008.02.043_bib18","first-page":"545","article-title":"Course of dermatomyositis-polymyositis: comparison of untreated and cortisone-treated patients","volume":"43","author":"Winkelmann","year":"1968","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2008.02.043_bib19","first-page":"283","article-title":"Polymyositis\/dermatomyositis: clinical features and outcome in 22 patients","volume":"12","author":"Baron","year":"1985","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0002-9343(83)90344-3","article-title":"Presentation, treatment, and prognosis of idiopathic inflammatory muscle disease in a rural hospital","volume":"75","author":"Hoffman","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2008.02.043_bib21","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1001\/archinte.1987.00370110117017","article-title":"Influence of age at onset on the duration of treatment in idiopathic adult polymyositis and dermatomyositis","volume":"147","author":"McKendry","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2008.02.043_bib22","first-page":"807","article-title":"Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis-dermatomyositis","volume":"15","author":"Oddis","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0002-9343(93)90148-I","article-title":"Drug therapy of the idiopathic inflammatory myopathies: Predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy","volume":"94","author":"Joffe","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2008.02.043_bib24","first-page":"213","article-title":"Polymyositis-dermatomyositis: 25 years of follow-up of 50 patients disease course, treatment, prognostic factors","volume":"22","author":"Chwalinska-Sadowska","year":"1990","journal-title":"Mater Med Pol"},{"key":"10.1016\/j.jaad.2008.02.043_bib25","first-page":"2230","article-title":"Polymyositis and dermatomyositis: short term and long term outcome, and predictive factors of prognosis","volume":"28","author":"Marie","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib26","first-page":"50","article-title":"Disease course, frequency of relapses and survival of 73 patients with juvenile or adult dermatomyositis","volume":"23","author":"Ponyi","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2008.02.043_bib28","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1590\/S0004-282X2002000600001","article-title":"Juvenile dermatomyositis: clinical, laboratorial, histological, therapeutical and evolutive parameters of 35 patients","volume":"60","author":"Sallum","year":"2002","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jaad.2008.02.043_bib29","first-page":"931","article-title":"Outcome in juvenile dermatomyositis","volume":"39","author":"Chowdhary","year":"2002","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.jaad.2008.02.043_bib30","first-page":"210","article-title":"A retrospective study of 13 oriental children with juvenile dermatomyositis","volume":"26","author":"See","year":"1997","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.jaad.2008.02.043_bib31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF02751533","article-title":"Juvenile dermatomyositis","volume":"63","author":"Seth","year":"1996","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.jaad.2008.02.043_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0190-9622(98)70496-7","article-title":"Dermatomyositis: a dermatology-based case series","volume":"38","author":"Dawkins","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib33","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1668::AID-MUS7>3.0.CO;2-#","article-title":"Frequency of relapses in patients with polymyositis and dermatomyositis","volume":"21","author":"Phillips","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaad.2008.02.043_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/08916930600622819","article-title":"National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary\u2013clinical characteristics and disease course of 44 patients with juvenile dermatomyositis","volume":"39","author":"Constantin","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaad.2008.02.043_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/rheumatology\/41.1.22","article-title":"Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality","volume":"41","author":"Sultan","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2008.02.043_bib36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0022-3476(84)80012-8","article-title":"Course of treated juvenile dermatomyositis","volume":"105","author":"Spencer","year":"1984","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2008.02.043_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/088307389801300303","article-title":"Drug therapy in juvenile dermatomyositis: follow-up study","volume":"13","author":"Ng","year":"1998","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jaad.2008.02.043_bib38","first-page":"407","article-title":"Dermatomyositis and polymyositis in childhood","volume":"35","author":"Chung","year":"1994","journal-title":"Acta Paed Sin"},{"key":"10.1016\/j.jaad.2008.02.043_bib39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T","article-title":"Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis","volume":"43","author":"Huber","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.02.043_bib40","first-page":"193","article-title":"Juvenile dermatomyositis in north India","volume":"34","author":"Singh","year":"1997","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.jaad.2008.02.043_bib41","first-page":"1527","article-title":"Juvenile dermatomyositis in Thai children","volume":"84","author":"Singalavanija","year":"2001","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jaad.2008.02.043_bib42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1090-3798(98)80021-4","article-title":"Childhood dermatomyositis: clinical course of 36 patients treated with low doses of corticosteroids","volume":"2","author":"Tabarki","year":"1998","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.jaad.2008.02.043_bib43","first-page":"263","article-title":"Long-term prognosis of 69 patients with dermatomyositis or polymyositis","volume":"14","author":"Maugars","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-5728(97)00033-7","article-title":"Pulsed intravenous methylprednisolone therapy for inflammatory myopathies: evaluation of the effect by comparing two consecutive biopsies from the same muscle","volume":"76","author":"Matsubara","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jaad.2008.02.043_bib45","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/jnnp.57.8.1008","article-title":"Pulsed intravenous methylprednisolone combined with oral steroids as the initial treatment of inflammatory myopathies","volume":"57","author":"Matsubara","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jaad.2008.02.043_bib46","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/art.1780300312","article-title":"Intravenous pulse methylprednisolone treatment of juvenile dermatomyositis","volume":"30","author":"Laxer","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.02.043_bib47","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0022-3476(96)70295-0","article-title":"Failure of pulse intravenous methylprednisolone treatment in juvenile dermatomyositis","volume":"128","author":"Lang","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2008.02.043_bib48","first-page":"621","article-title":"Long-term prognosis of patients with juvenile dermatomyositis initially treated with intravenous methylprednisolone pulse therapy","volume":"17","author":"Huang","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib49","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s100670050032","article-title":"Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate","volume":"19","author":"Al-Mayouf","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib50","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0387-7604(86)80107-3","article-title":"High-dose intravenous methyl-prednisolone in chronic polymyositis\/dermatomyositis","volume":"8","author":"Castro-Gago","year":"1986","journal-title":"Brain Dev"},{"key":"10.1016\/j.jaad.2008.02.043_bib51","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/ard.52.12.857","article-title":"Adult onset polymyositis\/dermatomyositis: clinical and laboratory features and treatment response in 75 patients","volume":"52","author":"Koh","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2008.02.043_bib52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000114893","article-title":"Methotrexate treatment in dermatomyositis","volume":"16","author":"Sarova-Pinhas","year":"1977","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jaad.2008.02.043_bib53","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-81-2-182","article-title":"Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy","volume":"81","author":"Metzger","year":"1974","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2008.02.043_bib54","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/0190-9622(95)91455-2","article-title":"Treatment of dermatomyositis with methotrexate","volume":"32","author":"Zieglschmid-Adams","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0190-9622(97)70327-X","article-title":"Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis","volume":"36","author":"Kasteler","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2008.02.043_bib56","first-page":"S53","article-title":"Randomized double blind trial of methotrexate and steroids compared with azathioprine and steroids in the treatment of idiopathic inflammatory myopathy","volume":"199","author":"Miller","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jaad.2008.02.043_bib57","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X","article-title":"Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens","volume":"41","author":"Villalba","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.02.043_bib58","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1542\/peds.59.2.212","article-title":"Methotrexate and azathioprine treatment of childhood dermatomyositis","volume":"59","author":"Jacobs","year":"1977","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2008.02.043_bib59","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/art.1780351006","article-title":"Methotrexate treatment of recalcitrant childhood dermatomyositis","volume":"35","author":"Miller","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.02.043_bib60","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/art.21378","article-title":"The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids","volume":"52","author":"Ramanan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.02.043_bib61","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/ard.41.6.557","article-title":"Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases","volume":"41","author":"Hollingworth","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2008.02.043_bib62","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0049-0172(90)90024-A","article-title":"Adult-onset polymyositis-dermatomyositis: Description of 25 patients with emphasis on treatment","volume":"20","author":"Ramirez","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.02.043_bib63","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-92-3-365","article-title":"Azathioprine with prednisone for polymyositis: a controlled, clinical trial","volume":"92","author":"Bunch","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2008.02.043_bib64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/art.1780240107","article-title":"Prednisone and azathioprine for polymyositis: long-term follow-up","volume":"24","author":"Bunch","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.02.043_bib65","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/adc.58.6.445","article-title":"Drug treatment of juvenile dermatomyositis","volume":"58","author":"Miller","year":"1983","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaad.2008.02.043_bib66","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/jnnp.54.11.1007","article-title":"Cyclosporin in the management of polymyositis and dermatomyositis","volume":"54","author":"Lueck","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jaad.2008.02.043_bib67","first-page":"2855","article-title":"Cyclosporin A in the treatment of refractory adult polymyositis\/dermatomyositis: population-based experience in 6 patients and literature review","volume":"27","author":"Qushmaq","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib68","first-page":"381","article-title":"Cyclosporine A as first choice therapy for dermatomyositis","volume":"21","author":"Grau","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib69","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/030097400750001897","article-title":"Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis","volume":"29","author":"Vencovsky","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib70","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(89)92456-2","article-title":"Cyclosporin in juvenile dermatomyositis","volume":"1","author":"Heckmatt","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2008.02.043_bib71","first-page":"2436","article-title":"Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis","volume":"24","author":"Reiff","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib72","first-page":"1719","article-title":"Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute\/subacute interstitial pneumonia in patients with dermatomyositis","volume":"32","author":"Kameda","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib73","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1191\/0961203305lu2158oa","article-title":"Polymyositis\/dermatomyositis-associated lung disease: analysis of a series of 81 patients","volume":"14","author":"Selva-O'Callaghan","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2008.02.043_bib74","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0091-6749(89)90199-1","article-title":"The use of intravenous immune globulin in collagen vascular disorders: a potentially new modality of therapy","volume":"84","author":"Gelfand","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2008.02.043_bib75","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/jnnp.55.1.60","article-title":"High-dose intravenous human immunoglobulin in polymyositis resistant to treatment","volume":"55","author":"Jann","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jaad.2008.02.043_bib76","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0002-9343(91)90009-M","article-title":"Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients","volume":"91","author":"Cherin","year":"1991","journal-title":"Am J Med"},{"issue":"Suppl","key":"10.1016\/j.jaad.2008.02.043_bib77","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/jnnp.57.Suppl.50","article-title":"Indications for intravenous gammaglobulin therapy in inflammatory myopathies","volume":"57","author":"Cherin","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jaad.2008.02.043_bib78","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jnnp.65.1.107","article-title":"Immunoglobulin therapy in inflammatory myopathies","volume":"65","author":"Mastaglia","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jaad.2008.02.043_bib79","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0002-9343(91)90010-U","article-title":"Treatment of dermatomyositis with intravenous gammaglobulin","volume":"91","author":"Lang","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2008.02.043_bib80","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/adc.72.1.25","article-title":"Intravenous immunoglobulin in juvenile dermatomyositis\u2013four year review of nine cases","volume":"72","author":"Sansome","year":"1995","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaad.2008.02.043_bib81","first-page":"2498","article-title":"Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety","volume":"27","author":"Al-Mayouf","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib82","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2008.02.043_bib83","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.intimp.2005.11.016","article-title":"The role of high-dose immune globulin intravenous in the treatment of dermatomyositis","volume":"6","author":"Dalakas","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaad.2008.02.043_bib84","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/ard.61.1.37","article-title":"Cyclosporin A and intravenous immunoglobulin treatment in polymyositis\/dermatomyositis","volume":"61","author":"Danieli","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2008.02.043_bib85","first-page":"1092","article-title":"Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients","volume":"21","author":"Cherin","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib86","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/03009740310002542","article-title":"Successful treatment of dermatomyositis-related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine","volume":"32","author":"Mok","year":"2003","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib87","first-page":"724","article-title":"Interstitial lung disease due to polymyositis or dermatomyositis: effect of a 6-month course of i.v. pulse cyclophosphamide","volume":"23","author":"Meyer","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib88","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/sarh.2002.50012","article-title":"Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment","volume":"32","author":"Schnabel","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.02.043_bib89","first-page":"658","article-title":"Combined steroid, methotrexate and chlorambucil therapy for steroid-resistant dermatomyositis","volume":"9","author":"Cagnoli","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib90","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/art.1780280523","article-title":"Combination immunosuppressive treatment of steroid-resistant dermatomyositis\/polymyositis","volume":"28","author":"Wallace","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.02.043_bib91","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/art.1780360305","article-title":"Chlorambucil: an effective corticosteroid-sparing agent for patients with recalcitrant dermatomyositis","volume":"36","author":"Sinoway","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.02.043_bib92","first-page":"1542","article-title":"Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases","volume":"27","author":"Gelber","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib93","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000051674","article-title":"Mycophenolate mofetil for dermatomyositis","volume":"202","author":"Tausche","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2008.02.043_bib94","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/mus.10026","article-title":"Mycophenolate mofetil in the therapy of polymyositis associated with a polyautoimmune syndrome","volume":"25","author":"Schneider","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaad.2008.02.043_bib95","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/rheumatology\/keh499","article-title":"Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy","volume":"44","author":"Majithia","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2008.02.043_bib96","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archderm.142.1.65","article-title":"Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis","volume":"142","author":"Edge","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib97","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1212\/01.wnl.0000208416.32471.c0","article-title":"Mycophenolate mofetil in dermatomyositis: is it safe?","volume":"66","author":"Rowin","year":"2006","journal-title":"Neurology"},{"issue":"Suppl","key":"10.1016\/j.jaad.2008.02.043_bib98","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaad.2004.05.044","article-title":"Rapamycin (sirolimus) as a steroid-sparing agent in dermatomyositis","volume":"52","author":"Nadiminti","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib99","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/ard.2004.029694","article-title":"Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2008.02.043_bib100","first-page":"1369","article-title":"Efficacy of rituximab in refractory polymyositis","volume":"32","author":"Lambotte","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib101","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.rhu.0000182155.08982.60","article-title":"Rituximab in the treatment of refractory dermatomyositis","volume":"11","author":"Chiappetta","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib102","first-page":"1021","article-title":"Rituximab as therapy for refractory polymyositis and dermatomyositis","volume":"33","author":"Noss","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib103","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","article-title":"Rituximab in the treatment of dermatomyositis: an open-label pilot study","volume":"52","author":"Levine","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.02.043_bib104","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archderm.143.6.763","article-title":"A pilot trial of rituximab in the treatment of patients with dermatomyositis","volume":"143","author":"Chung","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib105","first-page":"138","article-title":"Reversible posterior leukoencephalopathy syndrome after treatment of diffuse large B-cell lymphoma","volume":"30","author":"Haefner","year":"2007","journal-title":"Onkologie"},{"key":"10.1016\/j.jaad.2008.02.043_bib106","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jaad.2006.05.068","article-title":"Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases","volume":"56","author":"Dinh","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2008.02.043_bib107","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.jaad.2005.11.1090","article-title":"Case reports of etanercept in inflammatory dermatoses","volume":"54","author":"Norman","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2008.02.043_bib108","first-page":"S193","article-title":"Etanercept is effective in the treatment of polymyositis\/dermatomyositis which is refractory to conventional therapy including steroids and other disease modifying agents","volume":"43","author":"Saadeh","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"Suppl","key":"10.1016\/j.jaad.2008.02.043_bib109","first-page":"S193","article-title":"Anti-TNF blockage with infliximab (Remicade) in polymyositis and dermatomyositis","volume":"43","author":"Hengstman","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.02.043_bib110","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/rheumatology\/keh226","article-title":"Successful treatment of alveolar hypoventilation due to dermatomyositis with anti-tumor necrosis factor-alpha","volume":"43","author":"Korkmaz","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl","key":"10.1016\/j.jaad.2008.02.043_bib111","first-page":"S90","article-title":"Successful use of infliximab in a case of refractory juvenile dermatomyositis","volume":"44","author":"Nzeusseu","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.02.043_bib112","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/rheumatology\/keh539","article-title":"Advanced refractory polymyositis responding to infliximab","volume":"44","author":"Anandacoomarasamy","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2008.02.043_bib113","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/rheumatology\/keh285","article-title":"Refractory adult dermatomyositis with pneumatosis cystoides intestinalis treated with infliximab","volume":"43","author":"Selva-O'Callaghan","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2008.02.043_bib114","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/ard.2005.048744","article-title":"Possible role for tumor necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients","volume":"65","author":"Efthimiou","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2008.02.043_bib115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000070852","article-title":"Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations","volume":"50","author":"Hengstman","year":"2003","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jaad.2008.02.043_bib116","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000079547","article-title":"Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: long-term follow-up","volume":"52","author":"Hengstman","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jaad.2008.02.043_bib117","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2340\/00015555-0058","article-title":"Treatment of recalcitrant dermatomyositis with efalizumab","volume":"86","author":"Huber","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2008.02.043_bib118","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00431-004-1497-7","article-title":"Steroid-sparing effect of tacrolimus in a patient with juvenile dermatomyositis presenting poor bioavailability of cyclosporine A","volume":"163","author":"Yamada","year":"2004","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaad.2008.02.043_bib119","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2169\/internalmedicine.44.1197","article-title":"Successful treatment with tacrolimus in a case of refractory dermatomyositis","volume":"44","author":"Mitsui","year":"2005","journal-title":"Intern Med"},{"key":"10.1016\/j.jaad.2008.02.043_bib120","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJM199205213262102","article-title":"Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis","volume":"326","author":"Miller","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2008.02.043_bib121","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archneur.1981.00510090038003","article-title":"Plasmapheresis in idiopathic inflammatory myopathy: experience with 35 patients","volume":"38","author":"Dau","year":"1981","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jaad.2008.02.043_bib122","first-page":"270","article-title":"Plasma exchange in polymyositis and dermatomyositis: a multicenter study of 57 cases","volume":"13","author":"Cherin","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib123","first-page":"1340","article-title":"Resistive exercise in the rehabilitation of polymyositis\/dermatomyositis","volume":"20","author":"Escalante","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib124","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/rheumatology\/37.2.196","article-title":"Improvement of physical fitness and muscle strength in polymyositis\/dermatomyositis patients by a training program","volume":"37","author":"Wiesinger","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib125","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/rheumatology\/37.12.1338","article-title":"Benefit of 6 months long-term physical training in polymyositis\/dermatomyositis patients","volume":"37","author":"Wiesinger","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib126","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/rheumatology\/38.7.608","article-title":"Safety of a home exercise program in patients with polymyositis and dermatomyositis: a pilot study","volume":"38","author":"Alexanderson","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2008.02.043_bib127","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/030097400447679","article-title":"The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis","volume":"29","author":"Alexanderson","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib128","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0190-9622(84)80263-7","article-title":"Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine","volume":"10","author":"Woo","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib129","first-page":"1214","article-title":"The treatment of dermatomyositis with hydroxychloroquine","volume":"12","author":"James","year":"1985","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib130","first-page":"1545","article-title":"Adjunctive use of hydroxychloroquine in childhood dermatomyositis","volume":"16","author":"Olson","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib131","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/archderm.141.7.855","article-title":"Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study","volume":"141","author":"Ang","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib132","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archderm.1995.01690240035006","article-title":"Dermatomyositis without muscle weakness. long-term follow-up of 12 patients without systemic corticosteroids","volume":"131","author":"Cosnes","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib133","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archderm.138.9.1231","article-title":"Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus","volume":"138","author":"Pelle","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib134","first-page":"50","article-title":"Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis","volume":"12","author":"Yoshimasu","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2133.2003.05209_4.x","article-title":"Successful treatment of amyopathic dermatomyositis with topical tacrolimus","volume":"148","author":"Ueda","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib136","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archderm.138.1.114","article-title":"Dermatomyositis: practical aspects","volume":"138","author":"Jorizzo","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib137","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/09546630310018509","article-title":"Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study","volume":"15","author":"Hollar","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2008.02.043_bib138","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000079903","article-title":"Topical tacrolimus in cutaneous lesions of dermatomyositis: lack of effect in side-by-side comparison in five patients","volume":"209","author":"Garcia-Doval","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2008.02.043_bib139","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1365-4362.2002.01409.x","article-title":"Cutaneous involvement of dermatomyositis can respond to dapsone therapy","volume":"41","author":"Cohen","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archderm.142.1.70","article-title":"Improvement in dermatomyositis rash associated with the use of antiestrogen medication","volume":"142","author":"Sereda","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib141","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1365-2133.2005.06855.x","article-title":"Treatment for poikilodermatous erythema of dermatomyositis with the pulsed dye laser","volume":"153","author":"Yanagi","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib142","first-page":"102","article-title":"Regression of cutis calcinosis with diltiazem in adult dermatomyositis","volume":"15","author":"Abdallah-Lotf","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib143","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1067\/mjd.2002.122196","article-title":"Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis","volume":"47","author":"Fisler","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib144","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1046\/j.1365-2133.2001.04153.x","article-title":"An extremely severe case of cutaneous calcinosis with juvenile dermatomyositis, and successful treatment with diltiazem","volume":"144","author":"Ichiki","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib145","first-page":"1129","article-title":"Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications","volume":"28","author":"Harel","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib146","first-page":"1837","article-title":"Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy","volume":"32","author":"Ambler","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib147","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1067\/mpd.2001.112473","article-title":"New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment","volume":"138","author":"Mukamel","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2008.02.043_bib148","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0404.1982.tb03087.x","article-title":"Polymyositis\u2013treatment and prognosis: a study of 107 patients","volume":"65","author":"Henriksson","year":"1982","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jaad.2008.02.043_bib149","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780280303","article-title":"Prognostic factors in polymyositis\/dermatomyositis: a computer-assisted analysis of ninety-two cases","volume":"28","author":"Benbassat","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.02.043_bib150","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archderm.1990.01670290077012","article-title":"Prognostic factors and predictive signs of malignancy in adult dermatomyositis: a study of 32 cases","volume":"126","author":"Basset-Seguin","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib151","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","article-title":"Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases","volume":"83","author":"Danko","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2008.02.043_bib152","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s10067-005-1164-z","article-title":"Prognosis and mortality of polymyositis and dermatomyositis patients","volume":"25","author":"Airio","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib153","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11926-005-0048-1","article-title":"Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going?","volume":"7","author":"Huber","year":"2005","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jaad.2008.02.043_bib154","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0889-857X(02)00024-8","article-title":"Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes","volume":"28","author":"Ramanan","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jaad.2008.02.043_bib155","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-4362.2002.01648.x","article-title":"Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study","volume":"41","author":"Wakata","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib156","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1196\/annals.1361.047","article-title":"Cancer-associated myositis: clinical features and prognostic signs","volume":"1051","author":"Ponyi","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaad.2008.02.043_bib157","first-page":"433","article-title":"Retrospective study of polymyositis in Auckland over 10 years","volume":"92","author":"Ogle","year":"1980","journal-title":"N Z Med J"},{"key":"10.1016\/j.jaad.2008.02.043_bib158","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.rhu.0000164820.46979.52","article-title":"Retrospective review of the clinical manifestations and outcomes in Puerto Ricans with idiopathic inflammatory myopathies","volume":"11","author":"Rios","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib159","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1001\/archotol.1995.01890110072013","article-title":"Nasopharyngeal carcinoma with dermatomyositis: analysis of 12 cases","volume":"121","author":"Peng","year":"1995","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaad.2008.02.043_bib160","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/brain\/89.4.747","article-title":"Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis","volume":"89","author":"Rose","year":"1966","journal-title":"Brain"},{"key":"10.1016\/j.jaad.2008.02.043_bib161","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","article-title":"A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies","volume":"54","author":"Gerami","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib162","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-199905000-00001","article-title":"Influence of age on characteristics of polymyositis and dermatomyositis in adults","volume":"78","author":"Marie","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2008.02.043_bib163","first-page":"1921","article-title":"Interstitial lung disease related to dermatomyositis: comparative study with patients without lung involvement","volume":"23","author":"Grau","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.02.043_bib164","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/rheumatology\/keg040","article-title":"Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A","volume":"42","author":"Kobayashi","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2008.02.043_bib165","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780380907","article-title":"A longitudinal study of functional disability in a national cohort of patients with polymyositis\/dermatomyositis","volume":"38","author":"Clarke","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.02.043_bib166","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/rheumatology\/keh404","article-title":"Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis","volume":"44","author":"Ponyi","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2008.02.043_bib167","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00007611-199801000-00003","article-title":"Juvenile dermatomyositis and polymyositis: a follow-up study of long-term sequelae","volume":"91","author":"Collison","year":"1998","journal-title":"South Med J"},{"key":"10.1016\/j.jaad.2008.02.043_bib168","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2004.12.015","article-title":"Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life","volume":"54","author":"Hundley","year":"2006","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208002776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208002776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:11:08Z","timestamp":1759270268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962208002776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":168,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0190962208002776"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2008.02.043","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1120894.577160","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The treatment and prognosis of dermatomyositis: An updated review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2008.02.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}